Psychotropic Drug Use in Children Before, During Pandemic

JAMA Pediatrics

EMBARGOED FOR RELEASE: 11 A.M. (ET), TUESDAY, JANUARY 4, 2022

Media advisory: The full study is linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamapediatrics/fullarticle/10.1001/jamapediatrics.2021.5634?guestAccessKey=5075d45e-4965-429b-8101-96327155381b&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=010422

 

What The Study Did: Researchers investigated how the use of psychotropic drugs, including antidepressants and stimulants, changed among children and adolescents in Canada before and during the COVID-19 pandemic.

Authors: Christine Leong, B.Sc., B.Sc.(Pharm), Pharm.D., of the University of Manitoba in Winnipeg, Canada, is the corresponding author.

 

(doi:10.1001/jamapediatrics.2021.5634)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.